Descemet Stripping Endothelial Keratoplasty in Pediatric Patients with Congenital Hereditary Endothelial Dystrophy

Fan Yang,Jing Hong,Gege Xiao,Yun Feng,Rongmei Peng,Minshu Wang,Hongqiang Qu
DOI: https://doi.org/10.1016/j.ajo.2019.08.010
IF: 5.488
2020-01-01
American Journal of Ophthalmology
Abstract:PURPOSE: To report the long-term outcomes of Descemet stripping endothelial keratoplasty (DSEK) with suture-assisted donor lenticule insertion performed in different age groups for pediatric patients with congenital hereditary endothelial dystrophy (CHED). DESIGN: Retrospective case series. METHODS: Pediatric patients with CHED who underwent DSEK from January 2010 to January 2016 were enrolled. Patients were divided into 2 groups according to their ages: the infant group and the child group. Longterm clinical outcomes and complications were compared. RESULTS: Thirty eyes of 16 patients were included: 19 eyes (10 patients) in the child group and 11 eyes (6 patients) in the infant group. The average duration of follow-up was 4.08 +/- 1.90 years (range 2.5-8.5 years). Corneal transparency scores of the 2 groups on postoperative day 7 were not statistically different. The average postoperative best-corrected visual acuity (BCVA) in the infant group (logMAR 0.32 +/- 0.11) was better than that in the child group (logMAR 0.54 +/- 0.20; (P=.01). Thirty-three percent of cases in the child group and 86% of cases in the infant group had postoperative BCVA achieved or better than logMAR 0.4. Average endothelial cell loss in the child group was 31.21%+/- 9.17%. Lenticule detachment occurred in 3 cases in the child group. CONCLUSIONS: Improved visual outcomes could be achieved in infant patients with CHED after DSEK without significant complications. Suture-assisted donor lenticule insertion techniques, Descemet membrane stripping, and postoperative sedation are advocated technical points. ( (C) 2019 Elsevier Inc. All rights reserved.)
What problem does this paper attempt to address?